Xencor Correlations
XNCR Stock | USD 25.60 0.02 0.08% |
The current 90-days correlation between Xencor Inc and Edgewise Therapeutics is 0.11 (i.e., Average diversification). The correlation of Xencor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Xencor Correlation With Market
Very weak diversification
The correlation between Xencor Inc and DJI is 0.44 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xencor Inc and DJI in the same portfolio, assuming nothing else is changed.
Xencor |
Moving together with Xencor Stock
0.89 | VCYT | Veracyte | PairCorr |
0.77 | VERA | Vera Therapeutics | PairCorr |
0.65 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.71 | DSGN | Design Therapeutics | PairCorr |
0.7 | SABSW | SAB Biotherapeutics | PairCorr |
0.7 | DVAX | Dynavax Technologies | PairCorr |
0.87 | VRNA | Verona Pharma PLC | PairCorr |
0.85 | VSTM | Verastem Trending | PairCorr |
Moving against Xencor Stock
0.89 | VALN | Valneva SE ADR | PairCorr |
0.74 | ME | 23Andme Holding Upward Rally | PairCorr |
0.72 | DRRX | Durect | PairCorr |
0.54 | DNTH | Dianthus Therapeutics | PairCorr |
0.53 | DRMA | Dermata Therapeutics | PairCorr |
0.47 | A | Agilent Technologies Sell-off Trend | PairCorr |
0.39 | EQ | Equillium | PairCorr |
0.37 | DOMH | Dominari Holdings | PairCorr |
0.34 | VCNX | Vaccinex | PairCorr |
0.8 | DTIL | Precision BioSciences | PairCorr |
0.79 | VINC | Vincerx Pharma | PairCorr |
0.75 | VIRX | Viracta Therapeutics | PairCorr |
0.75 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.75 | VTGN | VistaGen Therapeutics | PairCorr |
0.61 | VRAX | Virax Biolabs Group | PairCorr |
0.51 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.49 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.41 | VIGL | Vigil Neuroscience | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Xencor Stock performing well and Xencor Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xencor's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EWTX | 3.41 | 0.71 | 0.27 | 0.39 | 2.67 | 6.65 | 61.02 | |||
KROS | 2.10 | 0.23 | 0.11 | 0.30 | 2.20 | 4.39 | 16.94 | |||
GLUE | 5.18 | 0.88 | 0.25 | 0.43 | 3.74 | 8.10 | 102.66 | |||
MLYS | 2.71 | (0.16) | 0.00 | 0.06 | 3.42 | 6.27 | 20.98 | |||
ERAS | 3.18 | (0.19) | (0.02) | 0.03 | 3.53 | 7.34 | 17.38 | |||
KURA | 2.40 | (0.77) | 0.00 | (5.58) | 0.00 | 4.98 | 42.52 | |||
PTGX | 1.93 | (0.14) | (0.03) | 0.04 | 2.31 | 3.70 | 14.61 | |||
MRUS | 1.66 | (0.35) | 0.00 | (0.18) | 0.00 | 3.08 | 10.85 | |||
REPL | 3.32 | 0.38 | 0.12 | 0.34 | 3.34 | 8.25 | 46.30 | |||
CERE | 0.77 | 0.06 | (0.05) | 0.49 | 0.94 | 1.91 | 6.40 |
Xencor Corporate Management
John Desjarlais | Chief Scientific Officer and Sr. VP of Research | Profile | |
Nancy MD | Executive Officer | Profile | |
Dane CFA | Senior Strategy | Profile | |
Jennifer Sandoz | Senior Resources | Profile | |
Kirk RAC | Senior Assurance | Profile |